Status:
COMPLETED
Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects
Lead Sponsor:
Ain Shams University
Conditions:
Periodontal Bone Loss
Eligibility:
All Genders
20-50 years
Phase:
EARLY_PHASE1
Brief Summary
The aim of the study is to evaluate the use of erythropoietin gel as an adjunct to xenograft in the surgical management of intrabony periodontal defects.
Detailed Description
In the periodontal disease there is an interaction of the biofilm with the immune response of the host which results in an imbalance between bacterial virulence and the host defense causing changes in...
Eligibility Criteria
Inclusion
- Both genders within age range of 20-50 years.
- Patients diagnosed with periodontitis (Stage III).
- Test site criteria: probing pocket depth ≥6mm and CAL ≥3mm. All these criteria will be determined after phase I conventional periodontal therapy.
- Patients with three-wall intrabony defect.
- Systemically free patients as evidenced by Burket's oral health history questionnaire .
- Ability to attend the treatment sessions and comply with its procedures, the recall visits and oral hygiene protocol.
Exclusion
- Smokers.
- Pregnant or lactating females.
- Patients under any medication that affect periodontal healing.
- Vulnerable individuals
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05360511
Start Date
July 1 2022
End Date
October 1 2023
Last Update
January 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry , Ain Shams University.
Cairo, Egypt